Goal to combine Ultima’s highly sensitive, low-cost technology with Quest’s oncology expertise and national scale in order to improve patient access, affordability and outcomes FREMONT, Calif & SECAUCUS, N.J. -- Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information services, today announced [...]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched a brand spanking new version of its hit product Stunner today. Stunner is the first instrument of its kind for the characterization of lipid nanoparticles (LNPs), racking up sizing, particle concentration, payload [...]

IK Partners (“IK”) and Mérieux Equity Partners (“MxEP”) are pleased to announce that the IK Small Cap II Fund and Mérieux Participations 3 have signed an agreement to sell their respective stakes in Mabtech AB (“Mabtech” or “the Company”), a Swedish biotechnology firm specialising in immune monitoring, to EQT. Financial terms of the contemplated transaction [...]

The new EQT Healthcare Growth Strategy builds on EQT’s 30-year healthcare track record and will focus on scaling innovative, fast-growing healthcare companies to help deliver positive outcomes across the value chain By helping companies build commercial muscle and expand their global reach, the Strategy aims to enable the development of medical research, diagnostics, tools and [...]

Bio-Link, a prominent Chinese bioprocessing company, and the French downstream bioprocessing company Verdot signed a strategic partnership agreement that marks a significant step forward in the field of biopharmaceutical manufacturing. The collaboration will see Bio-Link become the major distributor for Verdot’s innovative chromatography columns in the Chinese market. The partnership was facilitated by Cathay Capital [...]

Thermo Fisher and Evosep develop and promote robust high-throughput workflows for clinical proteomics ODENSE, Denmark -- Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving science. This collaboration marks a significant milestone in advancing clinical proteomics research by combining Evosep's cutting-edge [...]

Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc. (Nasdaq: ILMN). The agreement enables Devyser to develop and offer its in vitro diagnostic (IVD) tests on Illumina MiSeqDx next-generation sequencing (NGS) instrument in the United States and Europe. The IVD development agreement allows Devyser to perform regulatory registrations of its [...]

MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences. Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA AI into its [...]

Tokyo, Japan -- ThinkCyte today announced the launch of its new partnering program for the biopharmaceutical and diagnostics industry. The program is designed to help accelerate research and development of novel therapeutics and artificial intelligence (AI)-based approaches in life science. The program consists of three strategic arms; the Disease Profiling Platform, Platform, the Biopharma Platform, [...]

Nanologica's Chinese distributor Yunbo Technology has made another call-off against the agreement previously signed for the delivery of silica worth USD 14 million over a six-year period. This call-off amounts to approximately SEK 930 thousand. The delivery is the fourth that Nanologica has made since the company approved its silica-based media for preparative chromatography, NLAB [...]